¶ Retinal Pigment Epithelium (RPE) - Expanded
Retinal Pigment Epithelium (Rpe) Expanded is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Retinal Pigment Epithelium (RPE) is a single layer of hexagonal cells located between the photoreceptor layer and the choroid in the retina. RPE cells are essential for maintaining photoreceptor function and survival, and their dysfunction is central to age-related macular degeneration (AMD) and other retinal degenerative diseases.
- Shape: Cuboidal to columnar hexagonal cells
- Size: 10-15 μm diameter
- Junctions: Tight junctions forming the outer blood-retinal barrier
- Surface: Apical microvilli ensheathing photoreceptor outer segments
¶ Key Proteins and Markers
- RPE65 — RPE-specific enzyme essential for visual cycle
- CRALBP (RLBP1) — Cellular retinaldehyde-binding protein
- Bestrophin-1 (BEST1) — Chloride channel, mutation causes Best disease
- ZO-1 — Tight junction protein
- PE65 — Palmitoyl protein thioesterase
- PMEL17 — Melanosome protein
- Phagocytosis: RPE daily phagocytosis of shed photoreceptor outer segment discs
- Visual Cycle: Regeneration of 11-cis-retinal (vitamin A cycle)
- Ion Transport: Maintenance of ionic environment for phototransduction
- Nutrient Transport: Delivery of nutrients from choroid to photoreceptors
- Waste Removal: Clearance of metabolic waste from photoreceptors
- Tight junctions form the outer blood-retinal barrier
- Regulates passage of molecules between choroid and retina
- Prevents harmful substances from entering the retina
RPE dysfunction is the primary event in AMD pathogenesis:
- Accumulation of lipofuscin
- Drusen formation between RPE and Bruch's membrane
- Oxidative stress and mitochondrial dysfunction
- RPE cell death
- Photoreceptor degeneration
- Geographic lesions in macula
- VEGF overexpression by RPE
- Choroidal neovascularization
- Fluid leakage and scarring
Recent research suggests links between RPE dysfunction and AD:
- Amyloid-beta accumulation in RPE
- Tau pathology in RPE cells
- Common pathways including oxidative stress and inflammation
- Alpha-synuclein inclusions found in RPE of PD patients
- Melanosome dysfunction
- Possible diagnostic biomarker potential
- Anti-VEGF therapy: Ranibizumab, aflibercept, bevacizumab
- Complement inhibitors: Lampalizumab (failed in trials)
- Cell replacement: RPE cell transplantation
- Gene therapy: RPE65 gene therapy for LCA
- iPSC-derived RPE for transplantation
- RPE metabolic modulation
- Neurotrophic factor delivery
- Phagocytosis enhancement
- Oxidative stress: ROS accumulation, mitochondrial damage
- Inflammation: Complement activation, cytokine release
- Autophagy impairment: Lipofuscin accumulation
- ER stress: Protein misfolding, UPR activation
RPE-derived biomarkers for neurodegenerative diseases:
- Aβ40, Aβ42 in tears/aqueous humor
- Tau protein levels
- VEGF and anti-VEGF therapy response
- RPE-specific miRNAs
The study of Retinal Pigment Epithelium (Rpe) Expanded has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Boulton & Dayhaw-Barker, The role of the retinal pigment epithelium (2001)
- Strauss, The retinal pigment epithelium in visual function (2005)
- Kaarniranta et al., Age-related macular degeneration (2019)
- Bhise et al., iPSC-derived RPE for retinal disease (2021)
- Cheung et al., Retinal pigment epithelium in Alzheimer's disease (2020)